Cancerous tumor in muscle tissue.
During active treatment, medical records documenting the diagnosis and the course of surgery, radiation, chemotherapy, or other therapeutic procedures support the 100 percent rating. At the six-month post-treatment examination, the key question shifts to whether there has been any local recurrence or metastasis. Oncology records, imaging studies such as MRI or PET scans, biopsy results, and pathology reports can show whether the cancer has returned or spread. If VA rates residual impairment after confirming no recurrence or metastasis, records showing reduced strength, limited range of motion, nerve damage, or other lasting functional loss become relevant. Statements from you and people who know you describing how any remaining symptoms affect your ability to work, move, or carry out daily activities can also help document the degree of ongoing functional impairment.
Conditions that are often caused or made worse by this one. If you have any of these, they may be claimable as secondary service connection.
